Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Correction to: Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.

Bucciol G, Moens L, Payne K, Wollants E, Mekahli D, Levtchenko E, Vermeulen F, Tousseyn T, Gray P, Ma CS, Tangye SG, Van Ranst M, Brown JR, Breuer J, Meyts I.

J Clin Immunol. 2018 Nov;38(8):938-939. doi: 10.1007/s10875-018-0570-3.

PMID:
30430354
2.

Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.

Bucciol G, Moens L, Payne K, Wollants E, Mekahli D, Levtchenko E, Vermeulen F, Tousseyn T, Gray P, Ma CS, Tangye SG, Van Ranst M, Brown JR, Breuer J, Meyts I.

J Clin Immunol. 2018 Oct;38(7):748-752. doi: 10.1007/s10875-018-0558-z. Epub 2018 Oct 11. No abstract available. Erratum in: J Clin Immunol. 2018 Nov;38(8):938-939.

PMID:
30311057
3.

JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte rich large B-cell lymphoma.

Schuhmacher B, Bein J, Rausch T, Benes V, Tousseyn T, Vornanen M, Ponzoni M, Thurner L, Gascoyne R, Steidl C, Küppers R, Hansmann ML, Hartmann S.

Haematologica. 2018 Sep 13. pii: haematol.2018.203224. doi: 10.3324/haematol.2018.203224. [Epub ahead of print]

4.

ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.

Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, De Somer L, Dooley J, Tousseyn T, Hershfield M, Liston A, Wouters C.

Pediatrics. 2018 Sep;142(3). pii: e20172266. doi: 10.1542/peds.2017-2266.

PMID:
30139808
5.

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.

De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, Lintermans B, Goossens S, Lammens T, Van Roy N, Touzart A, Jenni S, Tsai YC, Lovisa F, Mussolin L, Serafin V, Van Nieuwerburgh F, Deforce D, Uyttebroeck A, Tousseyn T, Burkhardt B, Klapper W, De Moerloose B, Benoit Y, Macintyre E, Bourquin JP, Basso G, Accordi B, Bornhauser B, Meijerink J, Vandenberghe P, Van Vlierberghe P.

Haematologica. 2019 Jan;104(1):e17-e20. doi: 10.3324/haematol.2018.199257. Epub 2018 Aug 3. No abstract available.

6.

Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases.

Marcelis L, Berghen C, De Zutter A, Biesemans P, Vandenberghe P, Verhoef G, Gheysens O, Sagaert X, Dierickx D, Tousseyn T.

Mod Pathol. 2018 Sep;31(9):1457-1469. doi: 10.1038/s41379-018-0054-2. Epub 2018 May 15.

PMID:
29765143
7.

Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.

Zimmermann H, Babel N, Dierickx D, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Bachy E, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, Trappe RU.

Transplantation. 2018 Nov;102(11):1914-1923. doi: 10.1097/TP.0000000000002269.

PMID:
29757894
8.

Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis.

Wiels WA, Du Four S, Seynaeve L, Flamez A, Tousseyn T, Thal D, D'Haeseleer M.

Front Neurol. 2018 Apr 10;9:242. doi: 10.3389/fneur.2018.00242. eCollection 2018.

9.

Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.

Claerhout H, Van Aelst S, Melis C, Tousseyn T, Gheysens O, Vandenberghe P, Dierickx D, Boeckx N.

Eur J Haematol. 2018 Jun;100(6):603-612. doi: 10.1111/ejh.13056. Epub 2018 Apr 18.

PMID:
29532520
10.

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.

Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M.

Br J Haematol. 2018 Mar 12. doi: 10.1111/bjh.15156. [Epub ahead of print] No abstract available.

PMID:
29527667
11.

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.

García-Barchino MJ, Sarasquete ME, Panizo C, Morscio J, Martinez A, Alcoceba M, Fresquet V, Gonzalez-Farre B, Paiva B, Young KH, Robles EF, Roa S, Celay J, Larrayoz M, Rossi D, Gaidano G, Montes-Moreno S, Piris MA, Balanzategui A, Jimenez C, Rodriguez I, Calasanz MJ, Larrayoz MJ, Segura V, Garcia-Muñoz R, Rabasa MP, Yi S, Li J, Zhang M, Xu-Monette ZY, Puig-Moron N, Orfao A, Böttcher S, Hernandez-Rivas JM, Miguel JS, Prosper F, Tousseyn T, Sagaert X, Gonzalez M, Martinez-Climent JA.

J Pathol. 2018 May;245(1):61-73. doi: 10.1002/path.5060. Epub 2018 Mar 30.

PMID:
29464716
12.

Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax.

Vervloessem T, Akl H, Tousseyn T, De Smedt H, Parys JB, Bultynck G.

Oncotarget. 2017 Dec 4;8(67):111656-111671. doi: 10.18632/oncotarget.22898. eCollection 2017 Dec 19.

13.

Rheumatoid granulomatous disease and pachymeningitis successfully treated with rituximab.

Moeyersoons A, Verschueren P, Tousseyn T, De Langhe E.

Acta Clin Belg. 2018 Aug;73(4):307-312. doi: 10.1080/17843286.2017.1375193. Epub 2017 Sep 13.

PMID:
28901842
14.

Blinatumomab in relapsed/refractory diffuse large B cell lymphoma.

Van Dijck R, Janssens A, Dierickx D, Delforge M, Gheysens O, Tousseyn T, Verhoef G.

Ann Hematol. 2017 Oct;96(10):1759-1762. doi: 10.1007/s00277-017-3088-5. Epub 2017 Aug 5. No abstract available.

PMID:
28779352
15.

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.

van der Krogt JA, Bempt MV, Ferreiro JF, Mentens N, Jacobs K, Pluys U, Doms K, Geerdens E, Uyttebroeck A, Pierre P, Michaux L, Devos T, Vandenberghe P, Tousseyn T, Cools J, Wlodarska I.

Haematologica. 2017 Sep;102(9):1605-1616. doi: 10.3324/haematol.2016.146571. Epub 2017 Jun 28.

16.

Posterior Reversible Encephalopathy Syndrome in a Patient With Multiple System Atrophy.

Debray S, Van de Vondel S, Tousseyn T, Thal DR, Dewil M.

Mov Disord Clin Pract. 2017 May 25;4(5):789-790. doi: 10.1002/mdc3.12495. eCollection 2017 Sep-Oct. No abstract available.

17.

One biopsy, two diagnoses: statin-induced autoimmune myopathy in combination with extranodal marginal zone lymphoma.

Michiels S, Dierickx D, Taelman V, Tousseyn T, Lenaerts J, De Langhe E.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):717. Epub 2017 May 17. No abstract available.

PMID:
28516888
18.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, Ferbert A, Petri S, Hartmann C, Bornemann A, Meisel A, Petersen JA, Tousseyn T, Thal DR, Reimann J, De Jonghe P, Martin JJ, Van den Bergh PY, Schulz JB, Weis J, Claeys KG.

Orphanet J Rare Dis. 2017 May 11;12(1):86. doi: 10.1186/s13023-017-0640-2. Review.

19.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790
20.

A man with hypertrophic thighs.

Huskens M, Cypers G, Tousseyn T.

Pract Neurol. 2017 Jun;17(3):231-232. doi: 10.1136/practneurol-2016-001576. Epub 2017 Mar 18. No abstract available.

PMID:
28315829
21.

Highly sensitive assays are mandatory for the differential diagnosis of patients presenting with symptoms of mast cell activation: diagnostic work-up of 38 patients.

Van den Poel B, Kochuyt AM, Del Biondo E, Dewaele B, Lierman E, Tousseyn T, de Hertogh G, Vandenberghe P, Boeckx N.

Acta Clin Belg. 2017 Apr;72(2):123-129. doi: 10.1080/17843286.2017.1293312. Epub 2017 Mar 6.

PMID:
28262030
22.

Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.

Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D, Vanduffel W, Tousseyn T, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G.

J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23.

23.

Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.

Morscio J, Finalet Ferreiro J, Vander Borght S, Bittoun E, Gheysens O, Dierickx D, Verhoef G, Wlodarska I, Tousseyn T.

Mod Pathol. 2017 Mar;30(3):370-381. doi: 10.1038/modpathol.2016.199. Epub 2017 Jan 6.

24.

Cholinergic depletion and basal forebrain volume in primary progressive aphasia.

Schaeverbeke J, Evenepoel C, Bruffaerts R, Van Laere K, Bormans G, Dries E, Tousseyn T, Nelissen N, Peeters R, Vandenbulcke M, Dupont P, Vandenberghe R.

Neuroimage Clin. 2016 Dec 2;13:271-279. doi: 10.1016/j.nicl.2016.11.027. eCollection 2017.

25.

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S.

J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.

PMID:
27992268
26.

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.

Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah S, Rosner J, Smith MA, Nielsen C, Giné E, Telenius A, Ennishi D, Mungall A, Moore R, Morin RD, Johnson NA, Sehn LH, Tousseyn T, Dogan A, Connors JM, Scott DW, Steidl C, Marra MA, Gascoyne RD, Shah SP.

PLoS Med. 2016 Dec 13;13(12):e1002197. doi: 10.1371/journal.pmed.1002197. eCollection 2016 Dec.

27.

Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.

Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, Somers J, Bracke KR, Van Den Eynde K, Tousseyn T, Brusselle GG, Verbeken EK, Verschakelen J, Emonds MP, Van Raemdonck DE, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Int. 2017 Feb;30(2):134-143. doi: 10.1111/tri.12882. Epub 2016 Dec 8.

28.

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.

De Smedt L, Palmans S, Andel D, Govaere O, Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, Dekervel J, Tousseyn T, De Hertogh G, Prenen H, Tejpar S, Lambrechts D, Sagaert X.

Br J Cancer. 2017 Jan 3;116(1):58-65. doi: 10.1038/bjc.2016.382. Epub 2016 Nov 24.

29.

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.

Margolskee E, Jobanputra V, Jain P, Chen J, Ganapathi K, Nahum O, Levy B, Morscio J, Murty V, Tousseyn T, Alobeid B, Mansukhani M, Bhagat G.

Oncotarget. 2016 Jun 21;7(25):37636-37648. doi: 10.18632/oncotarget.9400.

30.

Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.

Morscio J, Tousseyn T.

World J Transplant. 2016 Sep 24;6(3):505-16. doi: 10.5500/wjt.v6.i3.505. Review.

31.

Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome.

Moens L, Frans G, Bosch B, Bossuyt X, Verbinnen B, Poppe W, Boeckx N, Slatter M, Brusselmans C, Diaz G, Tousseyn T, Flipts H, Corveleyn A, Dierickx D, Meyts I.

J Allergy Clin Immunol. 2016 Nov;138(5):1485-1489.e2. doi: 10.1016/j.jaci.2016.04.057. Epub 2016 Jul 12. No abstract available.

PMID:
27484033
32.

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.

Robles EF, Mena-Varas M, Barrio L, Merino-Cortes SV, Balogh P, Du MQ, Akasaka T, Parker A, Roa S, Panizo C, Martin-Guerrero I, Siebert R, Segura V, Agirre X, Macri-Pellizeri L, Aldaz B, Vilas-Zornoza A, Zhang S, Moody S, Calasanz MJ, Tousseyn T, Broccardo C, Brousset P, Campos-Sanchez E, Cobaleda C, Sanchez-Garcia I, Fernandez-Luna JL, Garcia-Muñoz R, Pena E, Bellosillo B, Salar A, Baptista MJ, Hernandez-Rivas JM, Gonzalez M, Terol MJ, Climent J, Ferrandez A, Sagaert X, Melnick AM, Prosper F, Oscier DG, Carrasco YR, Dyer MJ, Martinez-Climent JA.

Nat Commun. 2016 Jun 14;7:11889. doi: 10.1038/ncomms11889.

33.

Clinical case report: a rare cause of acute kidney failure - tissue is the issue.

Heggermont WA, Verhoef G, Evenepoel P, Sprangers B, Lerut E, Tousseyn T, Claes K.

Acta Clin Belg. 2017 Jun;72(3):201-204. doi: 10.1080/17843286.2016.1178967. Epub 2016 May 17.

PMID:
27253186
34.

Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.

Morscio J, Bittoun E, Volders N, Lurquin E, Wlodarska I, Gheysens O, Vandenberghe P, Verhoef G, Demaerel P, Dierickx D, Sagaert X, Janssens A, Tousseyn T.

J Hematop. 2016 May 21;9:113-120. doi: 10.1007/s12308-016-0273-8. eCollection 2016.

35.

Severe acute kidney injury as presentation of Burkitt's lymphoma.

ter Haar E, Labarque V, Tousseyn T, Mekahli D.

BMJ Case Rep. 2016 Apr 26;2016. pii: bcr2016214780. doi: 10.1136/bcr-2016-214780.

36.

Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.

Declercq L, Celen S, Lecina J, Ahamed M, Tousseyn T, Moechars D, Alcazar J, Ariza M, Fierens K, Bottelbergs A, Mariën J, Vandenberghe R, Andres IJ, Van Laere K, Verbruggen A, Bormans G.

Mol Imaging. 2016 Jan 27;15. pii: 1536012115624920. doi: 10.1177/1536012115624920. Print 2016.

37.

Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.

Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE, Deroose CM, Sagaert X, Wlodarska I, Verhoef G, Dierickx D, Tousseyn T.

Leuk Lymphoma. 2016 Oct;57(10):2382-8. doi: 10.3109/10428194.2016.1140162. Epub 2016 Feb 8.

PMID:
26854937
38.

Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.

Van Roosbroeck K, Ferreiro JF, Tousseyn T, van der Krogt JA, Michaux L, Pienkowska-Grela B, Theate I, De Paepe P, Dierickx D, Doyen C, Put N, Cools J, Vandenberghe P, Wlodarska I.

Genes Chromosomes Cancer. 2016 May;55(5):428-41. doi: 10.1002/gcc.22345. Epub 2016 Feb 6.

PMID:
26850007
39.

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.

Ferreiro JF, Morscio J, Dierickx D, Vandenberghe P, Gheysens O, Verhoef G, Zamani M, Tousseyn T, Wlodarska I.

Am J Transplant. 2016 Feb;16(2):414-25. doi: 10.1111/ajt.13558. Epub 2016 Jan 18.

40.

Mycobacterium genavense infection in a solid organ recipient: a diagnostic and therapeutic challenge.

Ombelet S, Van Wijngaerden E, Lagrou K, Tousseyn T, Gheysens O, Droogne W, Doubel P, Kuypers D, Claes KJ.

Transpl Infect Dis. 2016 Feb;18(1):125-31. doi: 10.1111/tid.12493. Epub 2016 Feb 3. Review.

PMID:
26688125
41.

Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.

Vandenberghe P, Wlodarska I, Tousseyn T, Dehaspe L, Dierickx D, Verheecke M, Uyttebroeck A, Bechter O, Delforge M, Vandecaveye V, Brison N, Verhoef GE, Legius E, Amant F, Vermeesch JR.

Lancet Haematol. 2015 Feb;2(2):e55-65. doi: 10.1016/S2352-3026(14)00039-8. Epub 2015 Jan 20.

PMID:
26687610
42.

Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy.

Weckhuysen D, Schrooten M, Demaerel P, Van Broeckhoven C, Tousseyn T, Kovacs GG, Van Damme P.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e173. doi: 10.1212/NXI.0000000000000173. eCollection 2015 Dec. No abstract available.

43.

Expression of FOXP1 and Colorectal Cancer Prognosis.

De Smedt L, Palmans S, Govaere O, Moisse M, Boeckx B, De Hertogh G, Prenen H, Van Cutsem E, Tejpar S, Tousseyn T, Sagaert X.

Lab Med. 2015 Fall;46(4):299-311. doi: 10.1309/LM7IHV2NJI1PHMXC.

PMID:
26489674
44.

How I treat posttransplant lymphoproliferative disorders.

Dierickx D, Tousseyn T, Gheysens O.

Blood. 2015 Nov 12;126(20):2274-83. doi: 10.1182/blood-2015-05-615872. Epub 2015 Sep 17.

45.

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.

Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, Van Den Bogaert K, Dierickx D, Vandecaveye V, Tousseyn T, Moerman P, Vanderstichele A, Vergote I, Neven P, Berteloot P, Putseys K, Danneels L, Vandenberghe P, Legius E, Vermeesch JR.

JAMA Oncol. 2015 Sep;1(6):814-9. doi: 10.1001/jamaoncol.2015.1883.

PMID:
26355862
46.

Diffuse 18F-FDG Muscle Uptake in Trichinella spiralis Infection.

Deroose CM, Van Weehaeghe D, Tousseyn T, Van Rompuy AS, Vanderschueren S, Blockmans D, Gheysens O.

Clin Nucl Med. 2016 Jan;41(1):55-6. doi: 10.1097/RLU.0000000000000933.

PMID:
26252328
47.

Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Tousseyn T, Bajsarowicz K, Sánchez H, Gheyara A, Oehler A, Geschwind M, DeArmond B, DeArmond SJ.

J Neuropathol Exp Neurol. 2015 Sep;74(9):873-88. doi: 10.1097/NEN.0000000000000228.

48.

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis.

De Smedt L, Lemahieu J, Palmans S, Govaere O, Tousseyn T, Van Cutsem E, Prenen H, Tejpar S, Spaepen M, Matthijs G, Decaestecker C, Moles Lopez X, Demetter P, Salmon I, Sagaert X.

Br J Cancer. 2015 Jul 28;113(3):500-9. doi: 10.1038/bjc.2015.213. Epub 2015 Jun 11.

49.

Single-centre 20-year experience with surgical treatment of thymic tumours.

Viskens S, Van Veer H, Tousseyn T, Coosemans W, Decaluwe H, Nafteux P, De Lyen P, Schoffski P, De Ruysscher D, Van Raemdonck D.

Acta Chir Belg. 2015 Jan-Feb;115:52-61.

PMID:
26021792
50.

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.

Al Assaf C, Van Obbergh F, Billiet J, Lierman E, Devos T, Graux C, Hervent AS, Emmerechts J, Tousseyn T, De Paepe P, Papadopoulos P, Michaux L, Vandenberghe P.

Haematologica. 2015 Jul;100(7):893-7. doi: 10.3324/haematol.2014.118299. Epub 2015 May 1.

Supplemental Content

Loading ...
Support Center